SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: prvtinvest who wrote (12165)7/2/2013 7:10:21 PM
From: mplaut1 Recommendation

Recommended By
Pogeu Mahone

  Read Replies (1) | Respond to of 13111
 
prvtinvest -

At the meeting, did they address at all the fact of their small staff? Maybe they really do not have enough staff with only 4, three of whom are senior scientists. Most companies have a bunch of lower-level (cheaper) people who spend a lot of time on the approval process. Maybe it would be a good idea to hire a few suitable people if they can find any in Knoxville.

Also was it clear whether a formal request of Breakthrough Designation had been submitted yet?

TIA



To: prvtinvest who wrote (12165)7/2/2013 11:08:02 PM
From: NTTG1 Recommendation

Recommended By
Pogeu Mahone

  Respond to of 13111
 
What have you read about people with finely tuned critical thinking skills?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News